| Detected | Trial | Change |
|---|---|---|
| 2026-08-12 | NCT03573700 Evaluation of CD19-Specific CAR Engineered Autologous T-Cells for Treatment of… |
date change Completion pushed: 2026-07-01 -> 2027-07-01 |
| 2026-07-24 | NCT07616154 Haploidentical Donor Hematopoietic Cell Transplant for Sickle Cell Disease |
Recruitment opened |
| 2026-07-24 | NCT06053268 Mindfulness Interventions to Improve Health Activation, Coping, and Stress Among… |
Primary endpoint(s) modified |
| 2026-07-23 | NCT03849651 TCRαβ-depleted Progenitor Cell Graft With Additional Memory T-cell DLI, Plus Selected Use… |
date change Completion pushed: 2026-06-07 -> 2027-12-31 |
| 2026-07-23 | NCT02530658 Next Generation Sequencing of Normal Tissues Prospectively in Pediatric Oncology Patients |
date change Primary completion pushed: 2033-12-31 -> 2045-12-31 |
| 2026-07-23 | NCT02530658 Next Generation Sequencing of Normal Tissues Prospectively in Pediatric Oncology Patients |
date change Completion pushed: 2038-12-31 -> 2053-12-31 |
| 2026-07-21 | NCT03226158 Next Generation Pathogen Sequencing for Prediction of Adverse Events |
date change Completion pushed: 2026-07-01 -> 2027-07-01 |
| 2026-07-21 | NCT05664113 Feasibility, Safety, and Potential Efficacy of Fecal Microbiota Transplantation (FMT) for… |
Primary endpoint(s) modified |
| 2026-07-19 | NCT07663539 Insights From Bereaved Parents and Oncologists |
Recruitment opened |
| 2026-07-19 | NCT07663539 Insights From Bereaved Parents and Oncologists |
date change Primary completion pushed: 2026-09 -> 2026-12 |
| 2026-07-19 | NCT07663539 Insights From Bereaved Parents and Oncologists |
date change Completion pushed: 2026-09 -> 2026-12 |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-07-22 | NCT07719972 Universal Newborn Screening For Sickle Cell Disease In Mozambique | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT06289673 | Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute… | Acute Lymphoblastic Leukemia | Recruiting |
| Phase 2/3 | |||
| NCT01046825 | Mature B-Cell Lymphoma And Leukemia Study III | Mature B-Cell Lymphoma | Active, Not Recruiting |
| NCT03117751 | Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and… | Acute Lymphoblastic Leukemia | Active, Not Recruiting |
| Phase 2 | |||
| NCT04558736 | Haploidentical HCT for Severe Aplastic Anemia | Aplastic Anemia | Recruiting |
| NCT05535166 | Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly… | Medulloblastoma | Recruiting |
| NCT05664126 | Haplo-identical Viral-Specific T-cells for Treatment of Cytomegalovirus and Adenovirus… | Cytomegalovirus | Recruiting |
| NCT06847269 | CAR T CELL Therapy for Pediatric, Adolescent and Young Adult Patients With CD19-Positive… | Acute Lymphoblastic Leukemia | Recruiting |
| NCT04968990 | Treatment of Newly Diagnosed Patient's With Wilm's Tumor Requiring Abdominal Radiation… | Wilms Tumor | Recruiting |
| NCT05583721 | Relationship Between Abnormal Myocardial Perfusion and Diastolic Dysfunction in Sickle… | Sickle Cell Disease | Recruiting |
| NCT06528691 | Entrectinib as a Single Agent in Upfront Therapy for Children <3 Years of Age With… | High Grade Glioma | Recruiting |
| NCT07428993 | Evaluating Efficacy of B7-H3-CAR T Cells Administered at the End of Upfront Map… | Pediatric Osteosarcoma | Recruiting |
| NCT07228741 | Resistance Exercise and Incretin Mimetic for Cardiometabolic Health in Survivors of ALL… | Acute Lymphoblastic Leukemia | Recruiting |
| NCT06023641 | Treatment of Newly Diagnosed Rhabdomyosarcoma Using Molecular Risk Stratification and… | Rhabdomyosarcoma | Recruiting |
| NCT06533748 | Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia… | Acute Lymphoblastic Leukemia | Recruiting |
| NCT07616154 | Haploidentical Donor Hematopoietic Cell Transplant for Sickle Cell Disease | Sickle Cell Disease | Recruiting |
| NCT07085338 | A Phase II Study With a Safety Run-In of the Addition of N-803 to a Chemoimmunotherapy… | Neuroblastoma Recurrent | Recruiting |
| NCT06390319 | Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed… | T-cell Acute Lymphoblastic Leukemia | Recruiting |
| NCT02790515 | Provision of TCRγδ T Cells and Memory T Cells Plus Selected Use of Blinatumomab in Naïve… | Acute Lymphoblastic Leukemia (ALL) | Active, Not Recruiting |
| NCT01878617 | A Clinical and Molecular Risk-Directed Therapy for Newly Diagnosed Medulloblastoma | Medulloblastoma | Active, Not Recruiting |
| NCT01946529 | Therapeutic Trial for Patients With Ewing Sarcoma Family of Tumor and Desmoplastic Small… | Desmoplastic Small Round Cell Tumor | Active, Not Recruiting |
| NCT02125786 | A Trial of Surgery and Fractionated Re-Irradiation for Recurrent Ependymoma | Ependymoma | Active, Not Recruiting |
| NCT00186992 | Radiation Therapy to Treat Musculoskeletal Tumors | Sarcoma, Ewing's | Active, Not Recruiting |
| NCT02114229 | Phase 2 Study of Alisertib Therapy for Rhabdoid Tumors | Malignant Rhabdoid Tumor | Active, Not Recruiting |
| NCT03164057 | A Trial of Epigenetic Priming in Patients With Newly Diagnosed Acute Myeloid Leukemia | Acute Myeloid Leukemia | Active, Not Recruiting |
| NCT04733534 | An Open-Label Intervention Trial to Reduce Senescence and Improve Frailty in Adult… | Frailty | Active, Not Recruiting |